AngioDynamics (ANGO) Earnings Date, Estimates & Call Transcripts $9.46 -0.11 (-1.15%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AngioDynamics Earnings Summary Latest Q3 Earnings DateApr. 2EstimatedConsensus EPS (Apr. 2) -$0.13 Actual EPS (Apr. 2) $0.03 Beat By $0.16 Actual Revenue (Apr. 2) $72.00MAngioDynamics issued Q3 2025 earnings on April 2, 2025, reporting an EPS of $0.03, which beat analysts' consensus estimates of -$0.13 by $0.16. Quarterly revenue fell 4.3% year-over-year to $72 million, above analyst estimates of $70.30 million. With a trailing EPS of -$1.01, AngioDynamics' earnings are expected to grow next year, from ($0.37) to ($0.26) per share. Q3 2025 Earnings ResourcesQ3 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)SEC FilingSlide DeckFull Screen Slide DeckPowered by Get AngioDynamics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AngioDynamics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataANGO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ANGO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads AngioDynamics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20252-$0.15-$0.13-$0.14 Q2 20252-$0.12-$0.10-$0.11 Q3 20252-$0.11-$0.10-$0.11 Q4 20252-$0.09-$0.08-$0.09 FY 20258-$0.47-$0.41-$0.44 Q1 20261-$0.13-$0.13-$0.13 Q2 20261-$0.10-$0.10-$0.10 Q3 20262-$0.07-$0.05-$0.06 Q4 20262-$0.02$0.00-$0.01 FY 20266-$0.32-$0.28-$0.30 Q1 20271-$0.09-$0.09-$0.09 Remove Ads AngioDynamics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails4/2/2025Q3 2025-$0.13$0.03+$0.16-$0.11$70.30M$72.00M1/8/2025Q2 2025-$0.11-$0.04+$0.07-$0.26$70.93M$72.90M10/3/2024Q1 2025-$0.15-$0.11+$0.04$0.09$67.93M$67.50M7/16/2024Q4 2024-$0.17-$0.06+$0.11$0.21$70.86M$71.00M4/4/2024Q3 2024-$0.14-$0.16 -$0.02$4.41$76.71M$75.18M1/5/2024Q2 2024-$0.09-$0.05+$0.04$0.62$81.65M$79.07M10/4/2023Q1 2024-$0.13-$0.12+$0.01-$1.39$77.70M$78.70M7/12/2023Q4 2023$0.02$0.02-$0.58$90.73M$91.10M AngioDynamics Earnings - Frequently Asked Questions When did AngioDynamics announce their last quarterly earnings? AngioDynamics (NASDAQ:ANGO) last announced its quarterly earning data on Wednesday, April 2, 2025. Learn more on ANGO's earnings history. What guidance has AngioDynamics issued on next quarter's earnings? AngioDynamics updated its FY25 earnings guidance on Wednesday, April, 2nd. The company provided EPS guidance of ($0.34)-($0.31) for the period, compared to the consensus earnings per share estimate of ($0.37). The company issued revenue guidance of $285-288 million, compared to the consensus revenue estimate of $284.89 million. Did AngioDynamics beat their earnings estimates last quarter? In the previous quarter, AngioDynamics (NASDAQ:ANGO) reported $0.03 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.13) by $0.16. Learn more on analysts' earnings estimate vs. ANGO's actual earnings. How can I listen to AngioDynamics's earnings conference call? The conference call for AngioDynamics's latest earnings report can be listened to online. Listen to Conference Call How can I read AngioDynamics's conference call transcript? The conference call transcript for AngioDynamics's latest earnings report can be read online. Read Transcript How can I view AngioDynamics's earnings report? AngioDynamics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does AngioDynamics generate each year? AngioDynamics (NASDAQ:ANGO) has a recorded annual revenue of $283.32 million. How much profit does AngioDynamics generate each year? AngioDynamics (NASDAQ:ANGO) has a recorded net income of -$184.35 million. ANGO has generated -$1.01 earnings per share over the last four quarters. What is AngioDynamics's EPS forecast for next year? AngioDynamics's earnings are expected to grow from ($0.37) per share to ($0.26) per share in the next year. More Earnings Resources from MarketBeat Related Companies Alphatec Earnings Results Integra LifeSciences Earnings Results Orthofix Medical Earnings Results Surmodics Earnings Results Accuray Earnings Results Rockwell Medical Earnings Results ReShape Lifesciences Earnings Results Abbott Laboratories Earnings Results Intuitive Surgical Earnings Results Boston Scientific Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s Next Remove Ads This page (NASDAQ:ANGO) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCould this be the start of AI’s Second Wind?We're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | SponsoredThis Crypto Is Set to Explode in JanuaryThe crypto summit Wall Street wants to stop Learn how to structure your portfolio like the top hedge funds...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANGO Stock Free ANGO Stock Alerts